# ROCKET I - Randomized Open Label Switch for Cholesterol Elevation on Kivexa Evaluation Trial

> **NCT00615810** · PHASE4 · COMPLETED · sponsor: **Gilead Sciences** · enrollment: 159 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Atripla
- **DRUG:** Kivexa plus Sustiva

## Key facts

- **NCT ID:** NCT00615810
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2009-10
- **Final completion:** 2010-01
- **Target enrollment:** 159 (ACTUAL)
- **Last updated:** 2010-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00615810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00615810, "ROCKET I - Randomized Open Label Switch for Cholesterol Elevation on Kivexa Evaluation Trial". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00615810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*